Untitled UI logotextLogo
Synapse Prescribe
Resources
icon of a pencil writing
Blog

Explore our latest articles and views.

news icon
Careers

Join us to modernize healthcare.

Webinars

Events, training, and live discussions.

Press

Press releases and media resources.

Toolbox

Coming soon.

Demo
Contact us

US

US
FR
JAP

Synapse Medicine Legal Notice

Published: June 2017; Updated: October 06, 2022
‍
This site, accessible at the URLhttp://synapse-medicine.com/fr(the “Site”), is published by Synapse Medicine Ink dba Synapse Global, a US subsidiary company of Synapse Medicine a French simplified joint stock company (SAS) with a capital of €35,403.44, registered at Bordeaux under the number 827 466 590, whose registered office is located at 17 rue Vauban, 33000 Bordeaux, represented by Dr. Clément Goehrs, CEO.
‍
The Director of the publication of the Site and the person in charge of the processing is Dr. Clément Goehrs.

The operator of the Synapse Medicine website can be reached at the following email address: contact@synapse-medicine.com
‍
Synapse Medicine’s application and Synapse Medicine user data are hosted by Microsoft Azure in the US whose headquarters are located at: Microsoft Corporation, One Microsoft Way, Redmond, XA 98052-6399, USA.

ONC Certified Health IT Disclaimer and Mandatory Disclosures

Synapse Medicine Inc's P.A.G.R. Prescriptions product v1.2  Certification No. 15.05.05.3167.EIRS.01.00.1.230807 on August 7, 2023 certified criteria (170.315(b)(3), 170.315(b)(10), 170.315(d)(1), 170.315(d)(2), 170.315(d)(3), 170.315(d)(5), 170.315(d)(6), 170.315(d)(7), 170.315(d)(8), 170.315(d)(12), 170.315(d)(13), 170.315(g)(3), 170.315(g)(4), 170.315(g)(5) with relied upon software by Surescripts. This Health IT Module is compliant with the ONC Certification Criteria for Health IT and has been certified by an ONC-ACB in accordance with the applicable certification criteria adopted by the Secretary of Health and Human Services. This certification does not represent an endorsement by the U.S. Department of Health and Human Services. No Additional Costs Apply

The P.A.G.R Prescriptions platform supports MFA in accordance with §170.315(d)(13). All providers must perform an ID verification before using the platform. The MFA is used on all controlled substance medications before submitting to a pharmacy, and to export data that may contain PHI.

b10 EHI Export Format Documentation
RWT plan 2025
RWT results 2024
RWT plan 2024
BlogPressWebinarsDocumentation
Untitled UI logomark
PrivacyLegal NoticeGeneral Conditions of Services
Synapse Medicine ©2025